SeaStar Medical Holding Price to Book Ratio 2021-2025 | ICU
Historical price to book ratio values for SeaStar Medical Holding (ICU) over the last 10 years. The current price to book ratio for SeaStar Medical Holding as of May 22, 2025 is 22.21.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
SeaStar Medical Holding Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-05-22 | 1.28 | 20.98 | |
2025-03-31 | 1.66 | $0.06 | 27.21 |
2024-12-31 | 1.94 | $-0.37 | -5.31 |
2024-09-30 | 4.26 | $-0.49 | -8.75 |
2024-06-30 | 7.59 | $-2.14 | -3.54 |
2024-03-31 | 18.35 | $-1.48 | -12.38 |
2023-12-31 | 11.08 | $-6.88 | -1.61 |
2023-09-30 | 6.60 | $-14.62 | -0.45 |
2023-06-30 | 13.00 | $-15.79 | -0.82 |
2023-03-31 | 46.50 | $-20.46 | -2.27 |
2022-12-31 | 102.50 | $-40.87 | -2.51 |
2022-09-30 | 257.00 | $-82.67 | -3.11 |
2022-06-30 | 254.00 | $-65.03 | -3.91 |
2022-03-31 | 253.00 | $-66.72 | -3.79 |
2021-12-31 | 251.00 | $-9.73 | -25.81 |
2021-09-30 | 251.00 | $-99.19 | -2.53 |
2021-06-30 | 247.75 | $30.26 | 8.19 |
2021-03-31 | 245.25 | $42.15 | 5.82 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.013B | $0.000B |
SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $134.174B | 25.17 |
Elevance Health (ELV) | United States | $86.874B | 11.21 |
CVS Health (CVS) | United States | $76.179B | 9.47 |
Cencora (COR) | United States | $56.230B | 19.56 |
DiDi Global (DIDIY) | China | $23.297B | 35.36 |
Natera (NTRA) | United States | $20.821B | 0.00 |
BioMerieux (BMXMF) | France | $15.355B | 0.00 |
Solventum (SOLV) | United States | $12.571B | 13.31 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
CochLear (CHEOY) | Australia | $11.391B | 0.00 |
Revvity (RVTY) | United States | $10.665B | 18.35 |
ICON (ICLR) | Ireland | $10.255B | 9.53 |
Viatris (VTRS) | United States | $9.976B | 3.43 |
Doximity (DOCS) | United States | $9.570B | 44.57 |
Avantor (AVTR) | United States | $8.763B | 12.73 |
HealthEquity (HQY) | United States | $8.657B | 42.59 |
Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
Sotera Health (SHC) | United States | $3.480B | 19.77 |
Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
Concentras Parent (CON) | United States | $2.744B | 15.86 |
Organon (OGN) | United States | $2.259B | 2.40 |
Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
Premier (PINC) | United States | $1.910B | 14.50 |
Progyny (PGNY) | United States | $1.791B | 39.42 |
PACS (PACS) | United States | $1.494B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.953B | 14.88 |
Agilon Health (AGL) | United States | $0.911B | 0.00 |
Nutex Health (NUTX) | United States | $0.901B | 13.61 |
AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
Embecta (EMBC) | United States | $0.614B | 4.14 |
InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
LifeMD (LFMD) | United States | $0.523B | 0.00 |
Enhabit (EHAB) | United States | $0.520B | 42.75 |
Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
SBC Medicals (SBC) | United States | $0.398B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
Oncology Institute (TOI) | United States | $0.226B | 0.00 |
Beauty Health (SKIN) | United States | $0.217B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
DocGo (DCGO) | United States | $0.137B | 22.33 |
OncoCyte (OCX) | United States | $0.098B | 0.00 |
So-Young (SY) | China | $0.088B | 0.00 |
Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
Biodesix (BDSX) | United States | $0.052B | 0.00 |
Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
ModivCare (MODV) | United States | $0.013B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |